219 related articles for article (PubMed ID: 10528790)
41. Fusidic acid resistance in Staphylococcus aureus.
Dobie D; Gray J
Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
[TBL] [Abstract][Full Text] [Related]
42. [Staphylococcus aureus infections--the clinical picture and treatment].
Gahrn-Hansen B; Espersen F; Frimodt-Møller N; Riegels-Nielsen P; Pedersen SS
Ugeskr Laeger; 2002 Aug; 164(32):3759-63. PubMed ID: 12362608
[TBL] [Abstract][Full Text] [Related]
43. Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin.
Kuo FC; Yen SH; Peng KT; Wang JW; Lee MS
BMC Infect Dis; 2016 Feb; 16():48. PubMed ID: 26830838
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
[TBL] [Abstract][Full Text] [Related]
45. Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
Ambler JE; Drabu YJ
J Hosp Infect; 1996 Jan; 32(1):71-82. PubMed ID: 8904376
[No Abstract] [Full Text] [Related]
46. Fusidic Acid and Its Major Active Metabolite Penetration into Cerebrospinal Fluid for Assessing Treatment of Intracranial Infections.
Rao Z; He ZF; Zheng MH; Dang ZL; Yang G; Zhang YH; Lu N; Wei YH
Chemotherapy; 2023; 68(1):48-54. PubMed ID: 35810737
[TBL] [Abstract][Full Text] [Related]
47. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
48. Simplifying the treatment of acute bacterial bone and joint infections in children.
Pääkkönen M; Peltola H
Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1125-31. PubMed ID: 22114963
[TBL] [Abstract][Full Text] [Related]
49. Role of linezolid in the treatment of orthopedic infections.
Bassetti M; Righi E; Di Biagio A; Rosso R; Beltrame A; Bassetti D
Expert Rev Anti Infect Ther; 2005 Jun; 3(3):343-52. PubMed ID: 15954851
[TBL] [Abstract][Full Text] [Related]
50. [Treatment of MRSA infections].
Borde JP; Kern WV
Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
[No Abstract] [Full Text] [Related]
51. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children.
Belthur MV; Phillips WA; Kaplan SL; Weinberg J
J Pediatr Orthop; 2010 Dec; 30(8):942. PubMed ID: 21102227
[No Abstract] [Full Text] [Related]
52. A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.
Pushkin R; Iglesias-Ussel MD; Keedy K; MacLauchlin C; Mould DR; Berkowitz R; Kreuzer S; Darouiche R; Oldach D; Fernandes P
Clin Infect Dis; 2016 Dec; 63(12):1599-1604. PubMed ID: 27682068
[TBL] [Abstract][Full Text] [Related]
53. Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance.
Heng YK; Tan KT; Sen P; Chow A; Leo YS; Lye DC; Chan RK
Int J Dermatol; 2013 Jul; 52(7):876-81. PubMed ID: 23432159
[TBL] [Abstract][Full Text] [Related]
54. Antibiotic treatment of gram-positive bone and joint infections.
Darley ES; MacGowan AP
J Antimicrob Chemother; 2004 Jun; 53(6):928-35. PubMed ID: 15117932
[TBL] [Abstract][Full Text] [Related]
55. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection.
Anguita-Alonso P; Hanssen AD; Osmon DR; Trampuz A; Steckelberg JM; Patel R
Clin Orthop Relat Res; 2005 Oct; 439():43-7. PubMed ID: 16205136
[TBL] [Abstract][Full Text] [Related]
56. Resistance to fusidic acid.
Turnidge J; Collignon P
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
[TBL] [Abstract][Full Text] [Related]
57. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
Faber C; Stallmann HP; Lyaruu DM; Joosten U; von Eiff C; van Nieuw Amerongen A; Wuisman PI
Antimicrob Agents Chemother; 2005 Jun; 49(6):2438-44. PubMed ID: 15917544
[TBL] [Abstract][Full Text] [Related]
58. Salvage therapy for complex bone and joint infections with ceftaroline: a multicentre, observational study.
Malandain D; Dinh A; Ferry T; Touchais S; Lustig S; Laurent F; Corvec S; Bémer P; Asseray N; Boutoille D
Int J Antimicrob Agents; 2017 Aug; 50(2):277-280. PubMed ID: 28689872
[No Abstract] [Full Text] [Related]
59. Beta-lactam therapy of osteomyelitis and septic arthritis.
Wilber RB
Scand J Infect Dis Suppl; 1984; 42():155-68. PubMed ID: 6396837
[TBL] [Abstract][Full Text] [Related]
60. [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)].
Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R;
Arch Pediatr; 2008 Oct; 15 Suppl 2():S74-80. PubMed ID: 19000859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
